Funding

Future Healthcare Leaders

is in our DNA

We provide catalytic capital to transformative healthcare companies at all stages.

Foresite Capital has been a key shareholder and partner during all parts of our growth over the years. They have a smart team that adds value.

Kurt Graves, Chairman, President & CEO

Intarcia Therapeutics

Foresite Capital has been a visionary partner.

Serge Saxonov, CEO & Co-Founder

10X Genomics

Foresite Capital is highly collaborative. Their team is supportive, well-informed and we are always happy to see them regularly at healthcare conferences and medical meetings.

Randy Schatzman, CEO

Alder Biopharmaceuticals

While we obviously value the financial component of Foresite Capital’s support, the greatest value comes from their genuine commitment to being a part of our team.

Terry Rosen, CEO

Arcus Biosciences

Foresite Capital introduced us to our strategic investor, Nestle Health Science, a great example of how the Foresite Capital team goes beyond investing to foster success.

Stephen Dilly, CEO

Aimmune

We have had the opportunity to work with a broad array of investors, but Foresite Capital distinguished itself from the pack as being an investor with a unique level of insight and access.

Othman Laraki, Co-Founder

Color Genomics

Foresite Capital uniquely understands data and biology.

Paul Dagum, Founder and CEO

Mindstrong

Foresite Capital invested in us at the absolute perfect time.

Vince Anido, CEO

Aerie Pharmaceuticals

A full lifecycle investor

We provide complete capital solutions at all stages to help build the next category-defining companies, because value creation goes beyond the IPO.

$1.2B

ASSETS

UNDER MANAGEMENT

3

FUNDS

CLOSED

30+

DIVERSE

TEAM MEMBERS